Investigating how metabolic processes affect neuron vulnerability in Alzheimer's disease.
Metabolic Mechanisms in Locus Coeruleus Neuron Vulnerability in Neurodegenerative Disease
This study is looking at how certain brain cells start to break down in Alzheimer's and similar diseases, using a special mouse model to learn more about what makes these cells vulnerable, which could help us understand how these conditions develop over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11099836 on NIH RePORTER |
What this research studies
This research focuses on understanding the early degeneration of locus coeruleus neurons in Alzheimer's disease and related neurodegenerative disorders. By studying a specific mouse model that lacks the mitochondrial enzyme GPT2, researchers aim to uncover the metabolic mechanisms that contribute to neuron vulnerability. The approach includes examining how these mechanisms operate across different stages of life and in response to environmental factors. This could lead to insights into the progression of Alzheimer's and similar conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing early symptoms.
Not a fit: Patients with neurodegenerative disorders not related to Alzheimer's or those who are not experiencing early symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease and related neurodegenerative disorders.
How similar studies have performed: Previous research has shown promising results in understanding neuron vulnerability in neurodegenerative diseases, but this specific approach using GPT2 is relatively novel.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Morrow, Eric M — Brown University
- Study coordinator: Morrow, Eric M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.